BioSpace News Archive

Press Releases

RAPT Therapeutics Announces FDA Clearance of IND Application to Proceed to Phase 2b Trial of RPT904 in Food Allergy

September 29, 2025
·
5 min read
Press Releases

CorWave Announces Presentation of Late Breaking Results from its First-In-Human Implant at HFSA Annual Scientific Meeting

September 29, 2025
·
4 min read
Press Releases

MannKind Appoints Dr. Ajay Ahuja as Executive Vice President and Chief Medical Officer

September 29, 2025
·
4 min read
Press Releases

Hanmi’s Oral Delivery Platform Compound Licensed to Gilead

September 29, 2025
·
2 min read
Press Releases

Enanta Pharmaceuticals Reports Positive Topline Results from its Phase 2b Study of Zelicapavir for the Treatment of Respiratory Syncytial Virus (RSV) in High-Risk Adults

September 29, 2025
·
13 min read
Press Releases

IO Biotech Provides Update Following Pre-BLA Meeting with FDA

September 29, 2025
·
6 min read
Press Releases

Dogwood Therapeutics Secures Exclusive Worldwide, Royalty Free License to Develop and Commercialize SP16 as a Treatment for Cancer Related Pain in an All-Stock Transaction Underscoring the Company’s Dedication to Improving the Lives of Cancer Patients

September 29, 2025
·
7 min read
Press Releases

Tonix Pharmaceuticals Plans to Initiate Prader-Willi Syndrome Phase 2 Trial of TNX-2900 (Intranasal Potentiated Oxytocin) in 2026

September 29, 2025
·
15 min read
Press Releases

AdvanCell to Highlight the Potential of Pb-212-based Targeted Alpha Therapies for Cancer at EANM’25

September 29, 2025
·
3 min read
Press Releases

Larimar Therapeutics Announces Positive Data from Ongoing Long-term Open Label Study and Updates to Nomlabofusp Program for Friedreich’s Ataxia

September 29, 2025
·
14 min read